DK1125929T3
(en )
2006-04-03
Process for Preparation of (-) - (2R, 4S) -4 - [(3,5-Bis-trifluoromethyl-benzyl) -methoxycarbonylamino] -2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1 1-carboxylic acid ethyl ester
MA28756B1
(en )
2007-07-02
CYCLIC UREA-SUBSTITUTED DERIVATIVES, THEIR PREPARATION AND THEIR PHARMACEUTICAL USE AS INHIBITORS OF KINASE
EP2153832A3
(en )
2011-06-22
Heterocyclic aspartyl protease inhibitors
EP2412707A3
(en )
2012-06-13
3-[2-(3-Amino-2-oxo-2H-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
SG166019A1
(en )
2010-11-29
Quinoline derivatives and use thereof as mycobacterial inhibitors
ATE358126T1
(en )
2007-04-15
NEW PROCESS FOR SYNTHESIS OF N-PHENYL-5-(4-FLUOROPHENYL)-1-(2-((2R,4R)-4-HYDROXY-6-OXOTETRAHYDROPYRAN-2-YL)ETHYL)-2-ISOPROPYL-4- PHENYL-1H-PYRROLE-3-CARBONIC ACID AMIDE
NO20045434L
(en )
2004-12-13
A combination of an NMDA antagonist and acetylcholinesterase inhibitors for the treatment of Alzheimer's disease
EP2436384A3
(en )
2012-09-19
Aripiprazole oral solution
HUP0401963A2
(en )
2005-01-28
Carboxylic acid derivative compounds and drugs comprising these compounds as the active ingredient
HUP0401740A3
(en )
2009-06-29
N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase and pharmaceutical compositions containing them
BG108225A
(en )
2005-04-30
Thiohydantoins and use thereof for treating diabetes
ZA200704913B
(en )
2008-09-25
3-[2-(3-acylamino-2-oxo-2H-pyridin-1-YL)-acetylamino]-4-oxo-pentanoic acid derivatives and their use as caspase inhibitors
ATE316962T1
(en )
2006-02-15
PYRIMIDINE DERIVATIVES AS SELECTIVE INHIBITORS OF COX-2
AP1766A
(en )
2007-08-10
Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
IS7061A
(en )
2003-11-28
Dihydrogen N-substituted and a-substituted diphenylalkoxy acetic acid amino alkyl esters and drugs containing said compounds
DK1778622T3
(en )
2010-05-25
Para-alkyl-substituted N- (4-hydroxy-3-methoxy-benzyl) -cinnamic acid amides and their use in the preparation of drugs
NZ236293A
(en )
1992-10-28
1-(alkyl or alkoxyalkyl)-4-phenyl piperidine-4-carboxylic acid amide derivatives; preparatory processes and pharmaceutical compositions
TH60795A
(en )
2004-02-13
Preparation of anhydrous CETP inhibitors
DE602005007604D1
(en )
2008-07-31
DIASTEREOSELECTIVE ADDITION OF LITHIATED N-METHYLIMIDAZOLE ON SULFINIMINES
AU2003210850A8
(en )
2003-09-02
N-substituted3-hydroxy-4-pyridinones and pharmaceuticals containing thereof
CY1105529T1
(en )
2010-07-28
THIOPHENE-REPLACED DEFENSE DERIVATIVES SUCH AS GLYT-1 INHIBITORS
ATE471316T1
(en )
2010-07-15
DIASTEREOSELECTIVE SYNTHESIS METHOD USING 6-BROMINE-4-(3-CHLORPHENYL)-2-METHOXYQUINOLINE
MY134349A
(en )
2007-12-31
Preparation of anhydrous cetp inhibitor
TH55865B
(en )
2003-03-21
Method of making 4-carboxymino-2-replaced -1,2,3,4-tetrahydroquinoline.
DE60316344D1
(en )
2007-10-25
CONTAINER, DEVICE AND METHOD FOR TESTING THE DISSOLUTION OF PHARMACEUTICAL COMPOSITIONS